Press Release | December 14, 2023
First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration
Read More
Press Release | December 7, 2023
Vittoria Biotherapeutics Announces FDA Clearance of IND Application for VIPER-101 to Treat T-Cell Lymphoma
Read More
Press Release | December 5, 2023
Dragonfly Therapeutics Initiates Phase 1/1b Study of its IL-2 Immunotherapy in Patients with Advanced Solid Tumors
Read More
Press Release | November 28, 2023
Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte
Read More
